Iveda Solutions, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-03-31; filed 2025-05-13.
0001641172-25-009950
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSCurrent report: 10-Q
Period ended 2025-06-30; filed 2025-08-14.
0001641172-25-023965
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 80 previous paragraphs and 87 current paragraphs.
75 unchanged; 5 reworded; 1 added; 0 removed; 0 previous and 6 current paragraphs rearranged.
Tables are not compared: 7 previous and 8 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
Results of Operations for the Six Months Ended June 30, 2025 Compared with the Six Months Ended June 30, 2024
Reworded paragraphs (5)
Previous wording
The decrease in net loss was primarily due to increased revenues and related gross margins and reduction in operating expenses for the three months ended March 31, 2025 compared to the same period in 2024.
Current wording
The decrease in net loss was primarily due to a reduction in operating expenses for the three months ended June 30, 2025 compared to the same period in 2024.
Previous wording
The increase in revenue for the three months ended March 31, 2025 compared with the same period in 2024 is attributable primarily to increased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term government contracts.
Current wording
The increase in revenue for the six months ended June 30, 2025 compared with the same period in 2024 is attributable primarily to increased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term government contracts and increased US revenues through its distributors.
Previous wording
As of March 31, 2025, we had cash and cash equivalents of $2.5 million compared to $2.7 million as of December 31, 2024. This decrease in our cash and cash equivalents for the three months ended March 31, 2025 is related to the operating losses during the three months ended March 31, 2025 offset by the collection of accounts receivables. There are no legal or economic factors that materially impact our ability to transfer funds between our U.S.-based and Taiwan-based segments.
Current wording
As of June 30, 2025, we had cash and cash equivalents of $1.6 million compared to $2.7 million as of December 31, 2024. This decrease in our cash and cash equivalents for the six months ended June 30, 2025 is related to the operating losses during the six months ended June 30, 2025. There are no legal or economic factors that materially impact our ability to transfer funds between our U.S.-based and Taiwan-based segments.
Previous wording
Net cash used in operating activities during the three months ended March 31, 2025 was ($0.1) million compared to ($1.1) million net cash used during the three months ended March 31, 2024. Net cash used in operating activities for the three months ended March 31, 2025 consisted primarily of the net loss of ($1.0) million. Other offsetting factors for the three months ended March 31, 2025 included $0.5 million cash provided from the collection of accounts receivable. Net cash used by operating activities for the three months ended March 31, 2024 consisted primarily of the net loss of ($1.3) million.
Current wording
Net cash used in operating activities during the six months ended June 30, 2025 was ($1.5) million compared to ($2.3) million net cash used during the six months ended June 30, 2024. Net cash used in operating activities for the six months ended June 30, 2025 consisted primarily of the net loss of ($1.4) million. Net cash used by operating activities for the six months ended June 30, 2024 consisted primarily of the net loss of ($1.9) million.
Previous wording
Net cash provided by financing activities for the three months ended March 31, 2025 were minimal compared with $0.5 million provided during the three months ended March 31, 2024. Net cash provided by financing activities in 2024 of $0.5 million proceeds from long term loans in Taiwan during the three months ended March 31, 2024.
Current wording
Net cash provided by financing activities for the six months ended June 30, 2025 were $0.3 million compared with $0.5 million provided during the six months ended June 30, 2024. Net cash provided by financing activities in 2025 included $0.2 from the sale of stock as compared to $0.5 million proceeds from long term loans in Taiwan during the six months ended June 30, 2024.
Rearranged current paragraphs (6)
Current report — wording carried from elsewhere
The decrease in revenue for the three months ended June 30, 2025 compared with the same period in 2024 is attributable primarily to decreased equipment sales from Iveda Taiwan as a result of delivery timing related to long-term government contracts offset by increased equipment sales in the US as distributor revenues increase.
Current report — wording carried from elsewhere
The table below sets forth the Net Revenue, Cost of Goods Sold, Operating Expenses, Other Income and Expenses, Tax Expense and Net Income by segment for each of the respective periods and a comparison period over period.
Current report — wording carried from elsewhere
The decrease in overall gross margin was primarily attributed to the lower margin larger government contract sales in Taiwan.
Current report — wording carried from elsewhere
The net decrease in operating expenses in the six months ended June 30, 2025 compared with the same period in 2024 is due primarily to a reduction in R&D expense in the US and no significant investor relations campaigns in the US based operations during this period.
Current report — wording carried from elsewhere
A majority of the decrease in loss from operations was primarily due to increased revenues and related gross margins and reduction in operating expenses.
Current report — wording carried from elsewhere
The decrease in net loss was primarily due to a reduction in operating expenses for the six months ended June 30, 2025 compared to the same period in 2024.